Aquestive Therapeutics
AQST
AQST
150 hedge funds and large institutions have $369M invested in Aquestive Therapeutics in 2025 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
30% more funds holding
Funds holding: 115 → 150 (+35)
18.31% more ownership
Funds ownership: 47.95% → 66.26% (+18%)
Holders
150
Holding in Top 10
3
Calls
$7.07M
Puts
$3.21M
Top Buyers
| 1 | +$34.9M | |
| 2 | +$14.7M | |
| 3 | +$14M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$8.77M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.45M |
Top Sellers
| 1 | -$9.45M | |
| 2 | -$8.85M | |
| 3 | -$1.83M | |
| 4 |
EAM
Everstar Asset Management
Mooresville,
North Carolina
|
-$1.62M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.35M |
